Cargando…
Are Tumor Marker Tests Applied Appropriately in Clinical Practice? A Healthcare Claims Data Analysis
Tumor markers (TM) are crucial in the monitoring of cancer treatment. However, inappropriate requests for screening reasons have a high risk of false positive and negative findings, which can lead to patient anxiety and unnecessary follow-up examinations. We aimed to assess the appropriateness of TM...
Autores principales: | Stollberg, Sabrina M., Näpflin, Markus, Nagler, Michael, Huber, Carola A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648915/ https://www.ncbi.nlm.nih.gov/pubmed/37958275 http://dx.doi.org/10.3390/diagnostics13213379 |
Ejemplares similares
-
Trends in Micronutrient Laboratory Testing in Switzerland: A 7-Year Retrospective Analysis of Healthcare Claims Data
por: Huber, Carola A, et al.
Publicado: (2020) -
Continuity of Care in Swiss Cancer Patients Using Claims Data
por: Blozik, Eva, et al.
Publicado: (2020) -
Initial prescriptions and medication switches of biological products: an analysis of prescription pathways and determinants in the Swiss healthcare setting
por: Wirth, Kevin, et al.
Publicado: (2023) -
Treatment patterns in patients using triptan and prophylactic medication: an analysis of clinical practice prior to the introduction of CGRP antagonists
por: Huber, Carola A, et al.
Publicado: (2019) -
Opioid prescriptions after knee replacement: a retrospective study of pathways and prognostic factors in the Swiss healthcare setting
por: Wirth, Kevin, et al.
Publicado: (2023)